Tag: NASDAQ:ACST

September 9, 2019

Acasti Pharma Receives Funding from the Government of Canada

Acasti Pharma (NASDAQ:ACST, TSXV:ACST) has announced the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) has awarded it...
July 28, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Acasti Up Again

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 21, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Acasta in Lead

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 4, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.
December 31, 2018

Acasti Pharma Announces Data on TRILOGY Phase 3 Trials of CaPre in Patients

Acasti Pharma (NASDAQ:ACST;TSXV:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre (omega-3...
December 30, 2018

5 Top Weekly NASDAQ Biotech Stocks: Dova Up 41 Percent

Dova Pharmaceuticals, Sesen Bio, Adaptimmune Therapeutics, Mustang Bio and Equillium were last week's top gainers.
November 14, 2018

Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019

Acasti Pharma (NASDAQ:ACST,TSXV:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid)...